NAION is considered the most common acute optic nerve disorder in older adults and is frequently associated with underlying vascular risk factors such as diabetes, high blood pressure, sleep apnea, cardiovascular disease, and other conditions affecting circulation
Cork told BBC Science Focus that licensing the drug for obesity treatment on the NHS is a positive step with the scientific community clear that Severe obesity is a disease that needs to be managed through drugs
Both Mounjaro and Wegovy require weekly subcutaneous injections, but their dose escalation schedules differ significantly
These changes reflect deeper physiologic progress that benefits long-term health regardless of the pace of weight loss
View Abstract [6] Hagen TM, Wierzbicka GT, Sillau AH, Bowman BB, Jones DP